SUNNYVALE, Calif., April 14 /PRNewswire-FirstCall/ -- Pharmacyclics, Inc. today announced that it will hold a conference call to discuss its third quarter 2008 financial results and achievements on Thursday, April 24, 2008, at 4:30 p.m. EDT (1:30 p.m. PDT).
To participate in the conference call, please dial 800-497-0451 for domestic callers and 706-758-3306 for international callers and reference conference passcode, 43624853. To access the live audio broadcast or the subsequent archived recording log on to http://ir.pharmacyclics.com. The archived version of the webcast will be available on the company’s website for one month.
About Pharmacyclics
Pharmacyclics is a pharmaceutical company developing innovative products to treat cancer and other serious diseases. The company is leveraging its small-molecule drug development expertise to build a pipeline in oncology and other diseases based on a wide range of targets, pathways and mechanisms. More information about the company, its technology, and products can be found at http://www.pharmacyclics.com. Pharmacyclics(R) and the “pentadentate” logo(R) are registered trademarks of Pharmacyclics, Inc.
CONTACT: Leiv Lea of Pharmacyclics, Inc., +1-408-774-0330; or Carolyn Wang
of WeissComm Partners, +1-415-946-1065, for Pharmacyclics, Inc.
Web site: http://www.pharmacyclics.com/
http://ir.pharmacyclics.com/
